MedPath

A Clinical trial to study the effects of Histaminum Hydrochloricum and Individualised Homoeopathic remedy in Allergic Rhinitis

Phase 2
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Registration Number
CTRI/2023/11/060158
Lead Sponsor
Surya T P
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Clinically diagnosed cases of allergic rhinitis

2. Both sexes of age 18-60 years

3. Patients with serum IgE level above 150 IU/ml or

Absolute Eosinophil Count level above 440

cells/microlitre.

Exclusion Criteria

1. Patients with severe systemic illnesses like Hypertension, Diabetes Mellitus.

2. Patients complicated with sinusitis,otitis media

3. Patients on other medication for allergic rhinitis

4. Patients with bronchial asthma

5. Pregnant ladies and lactating mothers

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in TNSS scoreTimepoint: once in a month for 1 year
Secondary Outcome Measures
NameTimeMethod
Reduction in IgE and AEC values.Timepoint: once in 3 months for 1 year
© Copyright 2025. All Rights Reserved by MedPath